In addition, in neurodegenerative diseases such as AD, the activated MAPK signaling pathway can also act on the NF-κB signaling pathway, promoting the release of TNF-α and IL-1β inflammatory factors to regulate the inflammatory response and further exacerbate neuronal damage in neurodegenerative diseases [165]. This evidence concerns the gene NFKB1 and neurodegenerative disease.